Currently out of the existing stock ratings of Stephanie Davis, 132 are a BUY (58.67%), 76 are a HOLD (33.78%), 17 are a SELL (7.56%).

Stephanie Davis

Work Performance Price Targets & Ratings Chart

Analyst Stephanie Davis, carries an average stock price target met ratio of 76.71% that have a potential upside of 19.5% achieved within 171 days. Previously, Stephanie Davis worked at LEERINK.

Stephanie Davis’s has documented 423 price targets and ratings displayed on 32 stocks. The coverage was on Healthcare, Technology sectors.

Most recent stock forecast was given on DGX, Quest Diagnostics at 31-Jan-2025.

Wall Street Analyst Stephanie Davis

Analyst best performing recommendations are on LVGO (LIVONGO HEALTH).
The best stock recommendation documented was for PHR (PHREESIA) at 3/31/2022. The price target of $29 was fulfilled within 1 day with a profit of $2.64 (10.02%) receiving and performance score of 100.15.

Average potential price target upside

of $40.62 (21.99%) on VEEV (VEEVA SYSTEMS).
of $17.89 (16.59%) on CAH (CARDINAL HEALTH).
of $17.79 (17.27%) on TDOC (TELADOC).

ACCD Accolade CERN Cerner Corp CPSI Computer Programs and Systems GDRX Goodrx Holdings HMSY HMS Holdings Corp HQY HealthEquity INOV Inovalon Holdings MDRX Allscripts Healthcare Solutions PHR Phreesia RCM R1 RCM TALK Talkspace TRHC Tabula Rasa HealthCare VCRA Vocera Communications VEEV Veeva Systems NUAN Nuance Communications NXGN Nextgen Healthcare PINC Premier TDOC Teladoc DOCS Doximity HCAT Health Catalyst ATHN athenahealth CHNG Change Healthcare EVH Evolent Health LVGO Livongo Health CAH Cardinal Health COR Cencora DGX Quest Diagnostics LFST Lifestance Health Group LH Laboratory of America Holdings OMCL Omnicell OPRX OPTIMIZERx Corp WBA Walgreens Boots Alliance

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Michael Cherny (LEERINK)